Ensign Peak Advisors’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $378K | Hold |
51,740
| – | – | ﹤0.01% | 1621 |
|
|
2025
Q1 | $491K | Hold |
51,740
| – | – | ﹤0.01% | 1558 |
|
|
2024
Q4 | $853K | Hold |
51,740
| – | – | ﹤0.01% | 1408 |
|
|
2024
Q3 | $763K | Hold |
51,740
| – | – | ﹤0.01% | 1464 |
|
|
2024
Q2 | $718K | Hold |
51,740
| – | – | ﹤0.01% | 1477 |
|
|
2024
Q1 | $813K | Sell |
51,740
-2,610
| -5% | -$41K | ﹤0.01% | 1447 |
|
|
2023
Q4 | $879K | Buy |
54,350
+19,250
| +55% | +$311K | ﹤0.01% | 1454 |
|
|
2023
Q3 | $432K | Hold |
35,100
| – | – | ﹤0.01% | 1628 |
|
|
2023
Q2 | $564K | Buy |
+35,100
| New | +$564K | ﹤0.01% | 1603 |
|
|
2022
Q4 | – | Sell |
-38,580
| Closed | -$332K | – | 2071 |
|
|
2022
Q3 | $332K | Sell |
38,580
-890
| -2% | -$7.66K | ﹤0.01% | 1659 |
|
|
2022
Q2 | $322K | Hold |
39,470
| – | – | ﹤0.01% | 1648 |
|
|
2022
Q1 | $480K | Hold |
39,470
| – | – | ﹤0.01% | 1567 |
|
|
2021
Q4 | $1.35M | Sell |
39,470
-63,530
| -62% | -$2.17M | ﹤0.01% | 1127 |
|
|
2021
Q3 | $4.97M | Hold |
103,000
| – | – | 0.01% | 665 |
|
|
2021
Q2 | $4.65M | Buy |
103,000
+16,800
| +19% | +$759K | 0.01% | 681 |
|
|
2021
Q1 | $4.16M | Buy |
86,200
+4,100
| +5% | +$198K | 0.01% | 707 |
|
|
2020
Q4 | $4.42M | Hold |
82,100
| – | – | 0.01% | 653 |
|
|
2020
Q3 | $3.03M | Hold |
82,100
| – | – | 0.01% | 776 |
|
|
2020
Q2 | $2.54M | Hold |
82,100
| – | – | 0.01% | 840 |
|
|
2020
Q1 | $2.27M | Buy |
82,100
+1,300
| +2% | +$35.9K | 0.01% | 777 |
|
|
2019
Q4 | $2.36M | Buy |
+80,800
| New | +$2.36M | 0.01% | 981 |
|